English
  1. Home
  2. Stocks
  3. Aartipharm Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Aarti Pharmalabs

    Mid Cap
    ₹615.15
    +1.15 (0.19%)
    18 May, 2024 14:37 BSE: 543748 NSE: AARTIPHARMISIN: INE0LRU01027

    Start SIP in Aarti Pharmalabs

    Start SIP

    Aarti Pharmalabs Performance

    Day Range

    • Low 605
    • High 621
    ₹ 615

    52 Week Range

    • Low 320
    • High 624
    ₹ 615
    • Open Price620
    • Previous Close614
    • Volume76816

    Aarti Pharmalabs Share Price

    • Over 1 Month +31.27%
    • Over 3 Month +14.68%
    • Over 6 Month +51.53%
    • Over 1 Year +70.43%

    Aarti Pharmalabs Key Statistics

    P/E Ratio 25.7
    PEG Ratio -1
    Market Cap Cr 5,575
    Price to Book Ratio 3.2
    EPS 22.1
    Dividend 0.3
    Relative Strength Index 72.36
    Money Flow Index 93.6
    MACD Signal 19.17
    Average True Range 26.09
    Aarti Pharmalabs Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 415373356358374
    Operating Expenses Qtr Cr 307285282281297
    Operating Profit Qtr Cr 10788747777
    Depreciation Qtr Cr 1717161514
    Interest Qtr Cr 44446
    Tax Qtr Cr 2819121517
    Net Profit Qtr Cr 6348424840
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,5131,513
    Operating Expenses Annual Cr 1,1561,203
    Operating Profit Annual in Cr 346308
    Depreciation Cr 6656
    Interest Annual Cr 1720
    Tax Annual Cr 7462
    Net Profit Annual Cr 201172
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 184229
    Cash from Investing Activity Annual Cr -184-116
    Cash from Financing Annual Activity Cr 4-157
    Net Cash Flow Annual Cr -43
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,6211,439
    Fixed Assets Annual Cr 1,090950
    Total Non Current Assets Annual Cr 1,1631,004
    Total Current Assets Annual Cr 1,134959
    Total Assets Annual Cr 2,2971,963
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 179159
    ROE Annual % 1212
    ROCE Annual % 1717
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2420
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 506449440458485
    Operating Expenses Qtr Cr 388353352373405
    Operating Profit Qtr Cr 11896888580
    Depreciation Qtr Cr 1919181716
    Interest Qtr Cr 54446
    Tax Qtr Cr 3121151716
    Net Profit Qtr Cr 6553524743
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,8581,948
    Operating Expenses Annual Cr 1,4671,603
    Operating Profit Annual in Cr 386342
    Depreciation Cr 7363
    Interest Annual Cr 1721
    Tax Annual Cr 8467
    Net Profit Annual Cr 217193
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 216263
    Cash from Investing Activity Annual Cr -215-158
    Cash from Financing Annual Activity Cr 10-163
    Net Cash Flow Annual Cr -58
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,7571,558
    Fixed Assets Annual Cr 1,1681,026
    Total Non Current Assets Annual Cr 1,2361,075
    Total Current Assets Annual Cr 1,3461,156
    Total Assets Annual Cr 2,5822,231
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 194172
    ROE Annual % 1212
    ROCE Annual % 1717
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2118
    Sign Up to Know More
    Invest in Aarti Pharmalabs

    Aarti Pharmalabs Technicals

    EMA & SMA

    Current Price
    ₹615.15
    +1.15 (0.19%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹535.83
    • 50 Day
    • ₹507.36
    • 100 Day
    • ₹489.90
    • 200 Day
    • ₹456.12
    • 20 Day
    • ₹531.57
    • 50 Day
    • ₹485.29
    • 100 Day
    • ₹501.28
    • 200 Day
    • ₹455.95

    Aarti Pharmalabs Resistance and Support

    PIVOT
    ₹611.34
    Resistance
    First Resistance 622.67
    Second Resistance 631.33
    Third Resistance 642.67
    RSI 72.36
    MFI 93.60
    MACD Single Line 19.17
    MACD 29.52
    Support
    First Support 602.67
    Second Support 591.33
    Third Supoort 582.67

    Aarti Pharmalabs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 502,471 16,516,222 32.87
    Week 2,366,563 68,109,683 28.78
    1 Month 738,879 25,240,123 34.16
    6 Month 369,460 16,012,395 43.34

    Aarti Pharmalabs Result Highlights

    Aarti Pharmalabs Synopsis

    NSE-Medical-Ethical Drugs

    Aarti Pharmalabs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1511.25 Cr. and Equity Capital is Rs. 45.31 Cr. for the Year ended 31/03/2023. Aarti Pharmalabs Ltd. is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964.
    Market Cap 5,564
    Sales 1,502
    Shares in Float 4.89
    No of funds 119
    Yield 0.33
    Book Value 3.41
    U/D Vol ratio 1.7
    LTDebt / Equity
    Alpha 0.09
    Beta 1.29

    Aarti Pharmalabs Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 46.46%46.46%46.3%45.98%
    Mutual Funds 2.72%2.05%2.67%2.72%
    Insurance Companies 6.49%7.03%7.03%7.06%
    Foreign Portfolio Investors 8.33%8.17%8.45%7.43%
    Financial Institutions/ Banks 0.02%0.02%0.02%0.02%
    Individual Investors 29.71%29.73%29.13%30.23%
    Others 6.27%6.54%6.4%6.56%

    Aarti Pharmalabs Management

    Name Designation
    Mr. Chandrakant Vallabhaji Gogri Chairman Emeritus
    Mr. Rashesh C Gogri Chairman & Non-Exe.Director
    Mrs. Hetal Gogri Gala Vice Chairperson & M.D
    Mr. Narendra J Salvi Managing Director
    Mr. Rajendra V Gogri Non Executive Director
    Mr. Parimal H Desai Non Executive Director
    Mr. Bhavesh R Vora Independent Director
    Mrs. Jeenal K Savla Independent Director
    Mrs. Rupal A Vora Independent Director
    Mr. Vilas Gajanan Gaikar Independent Director
    Mr. Vinay G Nayak Independent Director

    Aarti Pharmalabs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Aarti Pharmalabs Corporate Action

    Date Purpose Remarks
    2024-05-13 Audited Results & Final Dividend
    2024-02-07 Quarterly Results & Interim Dividend
    2023-11-07 Quarterly Results
    2023-08-05 Quarterly Results
    2023-05-12 Audited Results
    Date Purpose Remarks
    2024-02-19 INTERIM Rs.2.00 per share(40%)Interim Dividend

    Aarti Pharmalabs MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Flexi Cap Fund Growth 20,564
    HDFC Large and Mid Cap Fund Growth 18,692
    HDFC Multi Cap Fund Regular Growth 13,425
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,835
    Quant Business Cycle Fund Regular Growth 1,237

    Aarti Pharmalabs FAQs

    What is Share Price of Aarti Pharmalabs ?

    Aarti Pharmalabs share price is ₹615 As on 18 May, 2024 | 14:23

    What is the Market Cap of Aarti Pharmalabs ?

    The Market Cap of Aarti Pharmalabs is ₹5574.9 Cr As on 18 May, 2024 | 14:23

    What is the P/E ratio of Aarti Pharmalabs ?

    The P/E ratio of Aarti Pharmalabs is 25.7 As on 18 May, 2024 | 14:23

    What is the PB ratio of Aarti Pharmalabs ?

    The PB ratio of Aarti Pharmalabs is 3.2 As on 18 May, 2024 | 14:23

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.